Close

Agile Therapeutics (AGRX) Receive $3M in Non-Dilutive Funding from New Jersey

December 1, 2016 8:01 AM EST Send to a Friend
Agile Therapeutics, Inc. (Nasdaq: AGRX) received net proceeds of approximately $3 million in non-dilutive financing through the State of New ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login